Pfizer logo

Pfizer dividend paidNYSE: PFE

TTMAnnual

Dividend paid (quarterly)

$2.38 B
+$8.00 M+0.34%

30 June 2024

new highvs 3 years high
+8.92%vs 3 years low
97.56%vs. sector
Performance
Most recent+0.3%
1 year+2.9%
3 years+8.9%
5 years+18.8%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend paid (quarterly) performance

Most recent change
PFE+0.3%
AMGN+0.1%
DHR-2.0%
SYK+0.3%
BSX0.0%
1 year change
PFE+2.9%
AMGN+6.0%
DHR-1.5%
SYK+7.0%
BSX0.0%
3 years change
PFE+8.9%
AMGN+21.0%
DHR+2.6%
SYK+28.1%
BSX-100.0%
5 years change
PFE+18.8%
AMGN+39.3%
DHR+29.7%
SYK+56.4%
BSX0.0%

Dividend paid (quarterly) performance

PFEAMGNDHRISRGSYKSNYBSX
Most recent+0.3%+0.1%-2.0%-+0.3%-0.0%
1 year+2.9%+6.0%-1.5%-+7.0%-0.0%
3 years+8.9%+21.0%+2.6%-+28.1%--100.0%
5 years+18.8%+39.3%+29.7%-+56.4%-0.0%
FAQ

What is Pfizer dividend paid (quarterly)?

Pfizer dividend paid (quarterly) is $2.38 B

What is Pfizer dividend paid (quarterly) compared to its all-time maximum value?

Pfizer dividend paid (quarterly) is 100% of its all-time maximum value

What is Pfizer dividend paid (quarterly) compared to other companies from its sector (Healthcare)?

Pfizer dividend paid (quarterly) is higher than 97.56% of the companies in the same sector (Healthcare)

How has Pfizer dividend paid (quarterly) changed over the year?

Over the past year, Pfizer dividend paid (quarterly) has increased by 2.9%. During the same period, Amgen has increased by 6.0%, Danaher has decreased by 1.5%, Stryker has increased by 7.0%, Boston Scientific has not changed

How has Pfizer dividend paid (quarterly) changed over the 3 years?

During the last 3 years, Pfizer dividend paid (quarterly) has increased by 8.9%. Over the same period, Amgen has increased by 21.0%, Danaher has risen by 2.6%, Stryker has increased by 28.1%, Boston Scientific has gone down by 100.0%

How has Pfizer dividend paid (quarterly) changed over the 5 years?

For the past 5 years, Pfizer dividend paid (quarterly) has increased by 18.8%. In the same period, Amgen has increased by 39.3%, Danaher has risen by 29.7%, Stryker has increased by 56.4%, Boston Scientific has not changed